Urology · Poughkeepsie, NY
NPI
1285739235
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
50 Eastdale Ave N
Poughkeepsie, NY, 12603
Phone (845) 437-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$438K
16,024 services
Medicare patients, 2024
1,194
Average age 76
Drug cost, 2024
$687K
2,154 prescriptions
Company payments, 2025
$519
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P Solliday was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 3,300 times for 33 patients. In total Michael P Solliday billed 16,024 services in 127 codes, and Medicare paid $438K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,300 | 33 | $0.10 | $338 |
| 81003 Clinical Chemistry | Office | 1,539 | 903 | $2.19 | $3,375 |
| 99213 Office E&M - Established | Office | 1,070 | 762 | $72.99 | $78K |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 858 | 59 | $34.39 | $30K |
| 99214 Office E&M - Established | Office | 635 | 479 | $98.98 | $63K |
| 36415 Venipuncture Blood Collection | Office | 470 | 348 | $8.59 | $4,040 |
| 51798 Ultrasound - Nonspecific | Office | 332 | 254 | $9.40 | $3,121 |
| 84153 Clinical Chemistry | Office | 308 | 237 | $17.84 | $5,496 |
| 80053 Clinical Chemistry | Office | 209 | 161 | $10.30 | $2,153 |
| 52000 Cystourethroscopy | Office | 138 | 120 | $201.00 | $28K |
| 84403 Clinical Chemistry | Office | 134 | 88 | $25.10 | $3,364 |
| 84270 Clinical Chemistry | Office | 133 | 88 | $21.14 | $2,812 |
| 87086 Bacterial Culture | Office | 129 | 100 | $7.91 | $1,020 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 99 | 91 | $90.58 | $8,967 |
| 84154 Clinical Chemistry | Office | 95 | 80 | $18.02 | $1,712 |
By year: 2022 $396K for 14,850 services; 2023 $442K for 15,507 services; 2024 $438K for 16,024 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,539 | 903 | $2.19 | $3,375 |
| 87798 Infectious Agent Detection by DNA/RNA | 858 | 59 | $34.39 | $30K |
| 36415 Venipuncture Blood Collection | 470 | 348 | $8.59 | $4,040 |
| 84153 Clinical Chemistry | 308 | 237 | $17.84 | $5,496 |
| 80053 Clinical Chemistry | 209 | 161 | $10.30 | $2,153 |
| 84403 Clinical Chemistry | 134 | 88 | $25.10 | $3,364 |
| 84270 Clinical Chemistry | 133 | 88 | $21.14 | $2,812 |
| 87086 Bacterial Culture | 129 | 100 | $7.91 | $1,020 |
| 84154 Clinical Chemistry | 95 | 80 | $18.02 | $1,712 |
| 85025 Blood Count | 81 | 59 | $7.52 | $609 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael P Solliday prescribed most often to Medicare patients was Finasteride, with 441 prescriptions and refills. In total Michael P Solliday wrote 2,154 Medicare prescriptions that cost $687K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 441 | 1,266 | 154 | $6,582 |
| Tamsulosin Hcl Generic | 360 | 927 | 117 | $6,457 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 154 | 444 | 56 | $4,387 |
| Dutasteride Generic | 112 | 313 | 45 | $3,231 |
| Silodosin Generic | 94 | 277 | 42 | $11K |
| Ciprofloxacin Hcl Generic | 69 | 69 | 55 | $290 |
| Testosterone Generic | 67 | 122 | 28 | $25K |
| Xyosted Testosterone Enanthate | 59 | 132 | 21 | $83K |
| Testosterone Cypionate Generic | 53 | 122 | 25 | $4,282 |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 52 | 125 | 19 | $9,581 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 48 | 119 | 21 | $1,897 |
| Tadalafil Generic | 44 | 119 | 16 | $5,392 |
| Cefuroxime Cefuroxime Axetil | 44 | 48 | 30 | $487 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 38 | 43 | 22 | $278 |
| Gemtesa Vibegron | 35 | 85 | 15 | $39K |
Brand drugs: - claims; generic drugs: 1,938 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael P Solliday $519 ($519 in general payments such as food, travel and fees) from 14 companies. The largest payer was Urogen Pharma, Inc. with $89.36.
| Company | Payments | Amount |
|---|---|---|
| Urogen Pharma, Inc. URGN | 3 | $89.36 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $51.47 |
| Antares Pharma, Inc. | 2 | $49.88 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $40.34 |
| Merck Sharp & Dohme LLC MRK | 2 | $40.19 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $39.63 |
| Pfizer Inc. PFE | 2 | $33.73 |
| Dendreon Pharmaceuticals LLC | 1 | $33.11 |
| Ferring Pharmaceuticals Inc. | 1 | $31.54 |
| Tolmar, Inc. | 1 | $28.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.